Market Overview

Morning Market Movers

Related GPRC
Kandi Technologies Says SEC Won't Act On Probe
Morning Market Losers
Related GERN
Mid-Day Market Update: Pitney Bowes Drops On Earnings Miss; Lumber Liquidators Shares Climb
Mallinckrodt Initiates Amyotrophic Lateral Sclerosis Study

Celldex Therapeutics (NASDAQ: CLDX) surged 25.34% to $6.9190 at 9:54 am. Celldex Therapeutics announced final results from the company's randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer.

Guanwei Recycling (NASDAQ: GPRC) climbed 25.15% to $2.09. Guanwei Recycling's trailing-twelve-month ROE is 33.04%.

Geron (NASDAQ: GERN) surged 24.53% to $1.32. Geron reported positive clinical results from the Phase 2 trial of imetelstat in patients with essential thrombocythemia.

Intermec (NYSE: IN) shares advanced 22.68% to $9.79. Honeywell International (NYSE: HON) announced its plans to buy Intermec for $600 million.

Posted-In: Morning Market MoversNews Intraday Update Markets Movers


Related Articles (CLDX + GERN)

View Comments and Join the Discussion!

Partner Center